Skip to main content
Caplight Logo









HTuO Biosciences

HTuO Biosciences

Private
VancouverHealthcare & Life Scienceshttps://www.htuobio.com/

Last Round

Pre Seed

May 1, 2024

Total Funding Raised

$3.14M

Company Overview

HTuO Biosciences is a biotechnology company that develops advanced molecular simulation software capable of accurately predicting the behavior of molecules to accelerate drug optimization.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

drug discoverymolecular simulationcomputer-aided drug designCADDin-silico drug discoverylead optimizationphysics-based modelingsmall-molecule developmentbinding affinity predictionbiotech softwarecomputational biologyAI drug discoveryundruggable targetsmolecular modelingin-silico assays

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HTuO Biosciences Comparables

Compare HTuO Biosciences with similar companies based on industry and business-model similarity.

HTuO Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ångström AI
86%
Acellera Therapeutics Inc.
86%
TandemAI
82%

HTuO Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMay 1, 2024
AngelApr 20, 2022
Pre SeedSep 24, 2021

Key People

Founding team and executive leadership

Anthony Fejes

Chief Executive Officer and Co-founder

Founding Team

HTuO Biosciences Investors

Notable investors and investment history

HTuO Biosciences investors
InvestorRounds
Cognition FundAngel
WUTIF Management CorporationAngel
SWAN Venture FundPre Seed, Angel
York Angel InvestorsAngel
E-FundPre Seed, Angel
Adrenaline FundAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2022

    $1.5M raised from SWAN Venture Fund and E-Fund.

HTuO Biosciences Filings

Explore SEC and related filing metadata, where available.

HTuO Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about HTuO Biosciences's valuation, stock price, and market status.

Is HTuO Biosciences a public or private company?

HTuO Biosciences is a private company.

What is the current stock price of HTuO Biosciences?

HTuO Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is HTuO Biosciences worth (valuation)?

Valuation information for HTuO Biosciences is not publicly available.

Can I buy HTuO Biosciences stock?

HTuO Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was HTuO Biosciences's last funding round?

HTuO Biosciences's most recent funding round was Angel on April 20, 2022.

Who are the main investors in HTuO Biosciences?

Key investors in HTuO Biosciences include SWAN Venture Fund.

Will HTuO Biosciences IPO soon?

No public IPO plans have been announced for HTuO Biosciences.

How can I track HTuO Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HTuO Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVancouver
Employee Range17
Year Founded2020
Last FundingMay 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?